New Report Offers “Distorted View” of Biopharma Industry

This week, the Minority Staff of the U.S. Senate Committee on Finance released a report entitled, “A Tangled Web: An Examination of the Drug Supply and Payment Chains.” The report is the latest to look at the nation’s complex drug cost ecosystem.
More patients are finding that what they have to pay for prescription drugs is simply unaffordable. That’s why BIO has repeatedly called on policymakers to advance reforms that will help provide all patients affordable access to